|
|
|
|
|
|
|
Amphastar Pharma (AMPH)
|
|
19.31 -0.17 (-0.87%)
|
04-20 16:00
|
|
Open:
|
19.43
|
Pre. Close:
|
19.48
|
|
High:
|
19.61
|
Low:
|
19.25
|
|
Volume:
|
59,143
|
Market Cap:
|
895M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
19.652 - 19.77
|
19.77 - 19.858
|
|
Low:
|
18.967 - 19.124
|
19.124 - 19.241
|
|
Close:
|
19.105 - 19.336
|
19.336 - 19.507
|
|
|
|
Technical analysis (as of: 2018-04-20 4:27:24 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 23.37 One year: 27.30
|
|
Support:
|
Support1: 18.84 Support2: 18.11
|
|
Resistance:
|
Resistance1:
20.01 Resistance2: 23.37
|
|
Pivot:
|
19.10 
|
|
Moving Averages:
|
MA(5): 19.43 MA(20): 18.97
MA(100): 18.90 MA(250): 17.71
|
|
MACD:
|
MACD(12,26):
0.12 Signal(12,26,9): 0.07
|
|
%K %D:
|
%K(14,3): 73.22 %D(3): 80.36
|
|
RSI:
|
RSI(14): 53.55
|
|
52-Week:
|
High: 20.45
Low: 13.15 Change(%): 29.9
|
|
Average Vol(K):
|
3-Month: 19543
10-Days 10055
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.AMPH has closed below upper band by 34.7%. Bollinger Bands are 35.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-19T11:25:01-04:00
U.S. opioid prescriptions down 12% last year, largest drop in 25 years
2018-04-17T15:35:03-04:00
DEA aiming to collar production of opioids
2018-04-17T12:03:04-04:00
Sen. Sanders introduces bill to fine opioid makers for marketing practices
2018-04-11T05:49:01-04:00
Will Opiant Pharma Solve The Biggest Crisis That The FDA Is Currently Facing?
2018-03-29T14:04:10-04:00
Amphastar Pharmaceuticals (AMPH) Presents At Needham and Company 17th Annual Healthcare Conference - Slideshow
2018-03-24T06:06:29-04:00
MannKind Scripts Recover As Q1 Nears Completion
2018-03-22T08:00:00-04:00
Your Daily Pharma Scoop: Achaogen's Plazomicin, Eiger Provides Update On Llonafarnib, Eleven Biotherapeutics Obtains Funding
2018-03-21T07:10:14-04:00
Amphastar prevails over Momenta and Sandoz in patent case
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
